Your browser doesn't support javascript.
loading
Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma.
Perri, Giampaolo; Prakash, Laura; Qiao, Wei; Varadhachary, Gauri R; Wolff, Robert; Fogelman, David; Overman, Michael; Pant, Shubham; Javle, Milind; Koay, Eugene J; Herman, Joseph; Kim, Michael; Ikoma, Naruhiko; Tzeng, Ching-Wei; Lee, Jeffrey E; Katz, Matthew H G.
Affiliation
  • Perri G; The Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Prakash L; The Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Qiao W; The Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Varadhachary GR; The Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wolff R; The Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fogelman D; The Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Overman M; The Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pant S; The Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Javle M; The Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Koay EJ; The Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Herman J; The Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kim M; The Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ikoma N; The Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tzeng CW; The Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee JE; The Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Katz MHG; The Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ann Surg ; 271(6): 996-1002, 2020 06.
Article in En | MEDLINE | ID: mdl-31895709
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatectomy / Pancreatic Neoplasms / Postoperative Care / Adenocarcinoma / Neoplasm Staging / Antineoplastic Agents Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Ann Surg Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatectomy / Pancreatic Neoplasms / Postoperative Care / Adenocarcinoma / Neoplasm Staging / Antineoplastic Agents Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Ann Surg Year: 2020 Type: Article